Publikationen, an denen er mitarbeitet Cristian Smerdou Picazo (14)

2024

  1. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 869-879

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

2021

  1. A proteomic atlas of lineage and cancer-polarized expression modules in myeloid cells modeling immunosuppressive tumor-infiltrating subsets

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  2. Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma

    Scientific Reports, Vol. 11, Núm. 1

  3. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

    Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946

2015

  1. Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12

    Cancer Research, Vol. 75, Núm. 3, pp. 497-507

2014

  1. A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system

    Cellular and Molecular Life Sciences, Vol. 71, Núm. 23, pp. 4637-4651

  2. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas

    Human Gene Therapy, Vol. 25, Núm. 2, pp. 132-143

2010

  1. A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector

    New Biotechnology, Vol. 27, Núm. 2, pp. 138-148

2009

  1. Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma

    Journal of Virology, Vol. 83, Núm. 23, pp. 12266-12278

2008

  1. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability

    Virology, Vol. 376, Núm. 1, pp. 242-251

2007

  1. Biodistribution and tumor infectivity of Semliki Forest virus vectors in mice: Effects of re-administration

    Molecular Therapy, Vol. 15, Núm. 12, pp. 2164-2171

2006

  1. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector

    Cancer Research, Vol. 66, Núm. 3, pp. 1620-1629

2005

  1. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas

    Molecular Therapy, Vol. 12, Núm. 1, pp. 153-163